Abstract
The aim of this study was to investigate the severity of coronary artery disease (CAD) and the plaque composition in neuropathic type 2 diabetic subjects with and without Charcot neuroarthropathy (CN) undergoing multidetector computed tomography coronary angiography (MDCT-CA). The study was a single-center, observational, with unmatched case–control design. We selected 17 CN patients and 18 patients with diabetic neuropathy (DN) without CN. In all the patients, multidetector computed tomography was performed to assess the coronary artery calcium score (CACS) and degree of coronary artery stenosis. Patients were classified as positive in the presence of significant CAD if there was at least one stenosis >50 % on MDCT-CA. The invasive coronary angiography was performed in case of significant stenosis detected with MDCT-CA, both as reference to standard and eventually as treatment. Groups were matched for age, sex, and traditional CAD risk factors. As compared to DN individuals, CN exhibited higher rates of significant coronary stenoses (p = 0.027; OR 7.7 [1.3–43.5]). However, no significant differences were observed in the CACS, which reflects plaque burden, in the two groups (p = 0.759). No significant differences were observed comparing CACS distribution in all subjects for stenosis higher/equal or lower than 50 % (p = 0.320). Finally, no significant differences were observed comparing CACS distribution in CN and DN subjects for coronary stenoses higher/equal or lower than 50 %. Our results suggest that CN patients have a higher prevalence of severe coronary plaques compared to DN patients. Nevertheless, coronary plaques in CN patients did not exhibit an increased degree of calcification.
Similar content being viewed by others
References
Rydén L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ et al (2007) Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 28:88–136
Alexander CM, Landsman PB, Teutsch SM (2000) Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors, and prevalence of coronary heart disease. Am J Cardiol 86:897–902
The Bypass Angioplasty Revascularization Investigation (BARI) Investigators (1996) Comparison of coronary artery bypass surgery with angioplasty in patients with multivessel disease (correction 1997;336:147. N Engl J Med 335:217–225
American Diabetes Association (1998) Consensus development conference on the diagnosis of coronary heart disease in people with diabetes. Diabetes Care 21:1551–1559
Miller TD, Redberg RF, Wackers FJT (2006) Screening asymptomatic diabetic patients for coronary artery disease: why not? J Am Coll Cardiol 48:761–764
Young LH, Wackers FJ, Chyun DA, Davey JA, Barrett EJ, Taillefer R, Heller GV, Iskandrian AE, Wittlin SD, Filipchuk N, Ratner RE, Inzucchi SE, DIAD Investigators (2009) Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA 301:1547–1555
Rathmann W, Ziegler D, Jahnke M, Haastert B, Gries FA (1993) Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med 10:820–824
Liao D, Carnethon M, Evans GW, Cascio WE, Heiss G (2002) Lower heart rate variability is associated with the development of coronary heart diseases in individuals with diabetes: the Atherosclerosis Risk in Communities Study. Diabetes 51:3524–3531
Jeffcoate W, Lima J, Nobrega L (2000) The Charcot foot. Diabet Med 17:253–258
Mortality associated with acute Charcot foot and neuropathic foot ulceration and diabetes alone diabetes care (2009) 32:816–821
Taylor AJ, Cerqueira M, Hodgson JM, Mark D, Min J, O’Gara P, Rubin GD (2010) ACCF/SCCT/ACR/AHA/ASE/ASN/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance. Circulation 122:e525–e555
Young MJ, Breddy JL, Veves A, Boulton AJM (1994) The prediction of diabetic neuropathy foot using vibration perception threshold: a prospective study. Diabetes Care 17:557–560
Young MJ, Boulton AJM, Macleod AF, Williamd DRR, Sonksen PK (1993) A multicentre study of the prevalence of diabetic peripheral neuropathy in the UK hospital clinic population. Diabetologia 36:150–154
Ewing DJ, Clarke BF (1982) Diagnosis and management of diabetic autonomic neuropathy. Br Med J 285:916–918
Cavanagh PR, Young MJ, Adams JE, Vickers KL, Boulton AJM (1994) Radiographic abnormalities in the feet of patients with diabetic neuropathy. Diabetes Care 17:201–209
Tomas MB, Patel M, Marvin SE, Palestro CJ (2000) The diabetic foot. Br J Radiol 73:443–450
European Society of Hypertension-European Society of Cardiology Guidelines Committee (2003) European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 21(6):1011–1053
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285(19):2486–2497
Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report (1998) National Institutes of Health. Obes Res 6(Suppl 2):51S–209S
Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B et al (2001) Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286:421–426
Taylor AJ, Bindeman J, Feuerstein I, Cao F, Brazaitis M, O’Malley PG (2005) Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) project. J Am Coll Cardiol 46(5):807–814
Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15:827–832
Meijboom WB, Van Mieghem CAG, van Pelt N et al (2008) Comprehensive assessment of coronary artery stenoses: computed tomography coronary angiography versus conventional coronary angiography and correlation with fractional flow reserve in patients with stable angina. J Am Coll Cardiol 52:636–643
Austen WG, Edwards JE, Frye RL et al (1975) A reporting system on patients evaluated for coronary artery disease. Report of the ad hoc committee for grading of coronary artery disease, council on cardiovascular surgery, American Heart Association. Circulation 51:5–40
Nathan DM, Meigs J, Singer DE (1997) The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is … or is it. Lancet 350(Suppl 1):SI4–SI9
Kamalesh M, Feigenbaum H, Sawada S (2007) Assessing prognosis in patients with diabetes mellitus: the Achilles’ heel of cardiac stress imaging tests? Am J Cardiol 99(7):1016–1019
Beck MO, Silveiro SP, Friedman R, Clausell N, Gross JL (1999) Asymptomatic coronary artery disease is associated with cardiac autonomic neuropathy and diabetic nephropathy in type 2 diabetic patients. Diabetes Care 22(10):1745–1747
Jeffcoate WJ, Game F, Cavanagh PR (2005) The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes. Lancet 366:2058–2061
Libby P, Sukhova G, Lee RT, Galis ZS (1995) Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. J Cardiovasc Pharmacol 25:S9–S12
Tamaru M, Tomura K, Sakamoto S, Tezuka K, Tamatani T et al (1998) Interleukin-1 beta induces tissue- and cell-specific expression of adhesion molecules in vivo. Arterioscler Thromb Vasc Biol 18:1292–1303
Ikeda U, Ikeda M, Oohara T, Kano S, Yaginuma T (1990) Mitogenic action of interleukin-1 alpha on vascular smooth muscle cells mediated by PDGF. Atherosclerosis 84(2–3):183–188
Napoli CF, de Nigris Palinski W (2001) Multiple role of reactive oxygen species in the arterial wall. J Cell Biochem 82(4):674–682
Touyz RM, Schiffrin EL (2004) Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol 122(4):339–352
Cave AC, Brewer AC, Narayanapanicker A et al (2006) NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal 8(5–6):691–728
Li JM, Shah AM (2004) Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Integr Comp Physiol 287(5):R1014–R1030
Kaiser N, Sasson S, Feener EP, Boukobza-Vardi N, Higashi S, Moller DE, Davidheiser S, Przybylski RJ, King GL (1993) Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes 42:80–89
Giacco F, Brownlee M (2010) Oxidative stress and diabetic complications. Circ Res 107:1058–1070
Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615–1625
Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787–790
Nascimento NR, Lessa LM, Kerntopf MR, Sousa CM, Alves RS, Queiroz MG, Price J, Heimark DB, Larner J, Du X, Brownlee M, Gow A, Davis C, Fonteles MC (2006) Inositols prevent and reverse endothelial dysfunction in diabetic rat and rabbit vasculature metabolically and by scavenging superoxide. Proc Natl Acad Sci USA 103:218–223
Van Baal J, Hubbard R, Game F, Jeffcoate W (2010) Mortality associated with acute Charcot Foot and neuropathic foot ulceration. Diabetes Care 33(5):1086–1089
Conflict of interest
D. Pitocco, R. Marano, E. Di Stasio, G. Scavone, G. Savino, F. Zaccardi, A. Rizzi, F. Martini, T. Musella, V. Silvestri, F. Costantini, M. Galli, S. Caputo, L. Bonomo and G. Ghirlanda declare they have no conflict of interest.
Human and Animal Rights
All the procedures have been followed in accordance with the guidelines of our institutional ethics committee and have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
Informed Consent
All persons gave their informed consent prior to their inclusion in the study. No identifying details are shown in the manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by Massimo Federici.
D. Pitocco, R. Marano, and E. Di Stasio have contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Pitocco, D., Marano, R., Di Stasio, E. et al. Atherosclerotic coronary plaque in subjects with diabetic neuropathy: the prognostic cardiovascular role of Charcot neuroarthropathy—a case–control study. Acta Diabetol 51, 587–593 (2014). https://doi.org/10.1007/s00592-014-0559-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-014-0559-1